A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis

被引：20

作者：

Mascarenhas, J. ^{[1
]}

Kosiorek, H. ^{[2
]}

Prchal, J. ^{[3
]}

Yacoub, A. ^{[4
]}

Berenzon, D. ^{[5
]}

Baer, M. R. ^{[6
]}

Ritchie, E. ^{[7
]}

Silver, R. T. ^{[7
]}

Kessler, C. ^{[8
]}

Winton, E. ^{[9
]}

Finazzi, M. C. ^{[10
]}

Rambaldi, A. ^{[10
,11
]}

Vannucchi, A. M. ^{[12
]}

Leibowitz, D. ^{[13
]}

Rondelli, D. ^{[14
]}

Arcasoy, M. O. ^{[15
]}

Catchatourian, R. ^{[16
]}

Vadakara, J. ^{[17
]}

Rosti, V. ^{[18
]}

Hexner, E. ^{[19
]}

Kremyanskaya, M. ^{[1
]}

Sandy, L. ^{[1
]}

Tripodi, J. ^{[20
]}

Najfeld, V. ^{[20
]}

Farnoud, N. ^{[21
]}

Salama, M. E. ^{[22
]}

Weinberg, R. S. ^{[23
]}

Rampal, R. ^{[21
]}

Goldberg, J. D. ^{[24
,25
]}

Mesa, R. ^{[26
]}

Dueck, A. C. ^{[2
]}

Hoffman, R. ^{[1
]}

机构：

[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA

[2] Mayo Clin, Scottsdale, AZ USA

[3] Univ Utah, Sch Med, Div Hematol, Salt Lake City, UT USA

[4] Univ Kansas, Canc Ctr, Kansas City, KS USA

[5] Wake Forest Univ, Med Ctr, Wake Forest Hlth, Comprehens Canc Ctr, Winston Salem, NC 27101 USA

[6] Univ Maryland, Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA

[7] Weill Cornell Med Coll, New York, NY USA

[8] Georgetown Univ, Med Ctr, Washington, DC 20007 USA

[9] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA

[10] Azienda Socio Sanitaria Terr Papa Giovanni XXIII, Hematol, Bergamo, Italy

[11] Univ Milan, Dept Oncol, Milan, Italy

[12] Univ Florence, AOU Careggi, Ctr Res & Innovat Myeloproliferat Neoplasms, CRIMM, Florence, Italy

[13] Palo Alto Med Fdn Sutter Hlth, Oncol Dept, Sunnyvale, CA USA

[14] Univ Illinois, Div Hematol Oncol, Chicago, IL USA

[15] Duke Univ, Sch Med, Durham, NC USA

[16] John H Stroger Jr Hosp Cook Cty Chicago, Oncol Dept, Chicago, IL USA

[17] Geisinger Med Ctr, Danville, PA 17822 USA

[18] IRCCS Policlin San Matteo Fdn, Lab Biochem Biotechnol & Adv Diag, Ctr Study Myelofibrosis, 19 Viale Golgi, I-27100 Pavia, Italy

[19] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[20] Icahn Sch Med Mt Sinai, Dept Pathol & Med, New York, NY 10029 USA

[21] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA

[22] Mayo Med Labs, Rochester, MN USA

[23] New York Blood Ctr, New York, NY 10021 USA

[24] NYU, Sch Med, Dept Populat Hlth, New York, NY USA

[25] NYU, Sch Med, Dept Environm Med, New York, NY USA

[26] UT Hlth San Antonio Canc Ctr, San Antonio, TX USA

来源：

LEUKEMIA | 2019年 / 33卷 / 12期

关键词：

MYELOPROLIFERATIVE NEOPLASMS;

D O I：

10.1038/s41375-019-0524-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2974 / 2978

页数：5

共 50 条

[1] A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis
J. Mascarenhas
H. Kosiorek
J. Prchal
A. Yacoub
D. Berenzon
M. R. Baer
E. Ritchie
R. T. Silver
C. Kessler
E. Winton
M. C. Finazzi
A. Rambaldi
A. M. Vannucchi
D. Leibowitz
D. Rondelli
M. O. Arcasoy
R. Catchatourian
J. Vadakara
V. Rosti
E. Hexner
M. Kremyanskaya
L. Sandy
J. Tripodi
V. Najfeld
N. Farnoud
M. E. Salama
R. S. Weinberg
R. Rampal
J. D. Goldberg
R. Mesa
A. C. Dueck
R. Hoffman
[J]. Leukemia, 2019, 33 : 2974 - 2978
[2] Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea
Yacoub, Abdulraheem
Mascarenhas, John
Kosiorek, Heidi
Prchal, Josef T.
Berenzon, Dmitry
Baer, Maria R.
Ritchie, Ellen
Silver, Richard T.
Kessler, Craig
Winton, Elliott
Finazzi, Maria Chiara
Rambaldi, Alessandro
Vannucchi, Alessandro M.
Leibowitz, David
Rondelli, Damiano
Arcasoy, Murat O.
Catchatourian, Rosalind
Vadakara, Joseph
Rosti, Vittorio
Hexner, Elizabeth
Kremyanskaya, Marina
Sandy, Lonette
Tripodi, Joseph
Najfeld, Vesna
Farnoud, Noushin
Papaemmanuil, Elli
Salama, Mohamed
Singer-Weinberg, Rona
Rampal, Raajit
Goldberg, Judith D.
Barbui, Tiziano
Mesa, Ruben
Dueck, Amylou C.
Hoffman, Ronald
[J]. BLOOD, 2019, 134 (18) : 1498 - 1509
[3] Pegylated interferon alfa-2a is effective and decreases LDH levels in patients with essential thrombocythemia and polycythemia vera
Ekinci, O.
[J]. LEUKEMIA RESEARCH, 2019, 85 : S27 - S27
[4] Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responses
Tashi, Tsewang
Swierczek, Sabina
Kim, Soo Jin
Salama, Mohamed E.
Song, Jihyun
Heikal, Nahla
King, Katherine Y.
Hickman, Kim
Litton, Scott
Prchal, Josef T.
[J]. LEUKEMIA, 2018, 32 (08) : 1830 - 1833
[5] Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responses
Tsewang Tashi
Sabina Swierczek
Soo Jin Kim
Mohamed E. Salama
Jihyun Song
Nahla Heikal
Katherine Y. King
Kim Hickman
Scott Litton
Josef T. Prchal
[J]. Leukemia, 2018, 32 : 1830 - 1833
[6] Final Results of Prospective Treatment with Pegylated Interferon Alfa-2a for Patients with Polycythemia Vera and Essential Thrombocythemia in First and Second-Line Settings
Yacoub, Abdulraheem
Mascarenhas, John
Mesa, Ruben A.
Kosiorek, Heidi E.
Rampal, Raajit K.
Silver, Richard T.
Salama, Mohamed E.
Siwoski, Olivia
Dueck, Amylou C.
Sandy, Lonette
McMullin, Mary Frances
Ewing, Joanne
O'Connell, Casey L.
Mead, Adam J.
De Stefano, Valerio
Weinberg, Rona Singer
Baer, Maria R.
Kessler, Craig M.
Winton, Elliott F.
Vannucchi, Alessandro M.
Kremyanskaya, Marina
Vadakara, Joseph
Rosti, Vittorio
Hexner, Elizabeth O.
Rondelli, Damiano
Arcasoy, Murat O.
Rambaldi, Alessandro
Ritchie, Ellen K.
Barbui, Tiziano
Kiladjian, Jean-Jacques
Harrison, Claire N.
Prchal, Josef T.
Hoffman, Ronald
[J]. BLOOD, 2019, 134
[7] Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera
Quintas-Cardama, Alfonso
Kantarjian, Hagop
Manshouri, Taghi
Luthra, Rajyalakshmi
Estrov, Zeev
Pierce, Sherry
Richie, Mary Ann
Borthakur, Gautam
Konopleva, Marina
Cortes, Jorge
Verstovsek, Srdan
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (32) : 5418 - 5424
[8] Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis
Alberto Alvarez-Larrán
Arturo Pereira
Marta Magaz
Juan Carlos Hernández-Boluda
Marta Garrote
Beatriz Cuevas
Francisca Ferrer-Marín
M. Teresa Gómez-Casares
Valentín García-Gutiérrez
M. Isabel Mata-Vázquez
Fanny Turon
Virginia Hernandez-Gea
Eduardo Arellano-Rodrigo
Francisco Cervantes
Juan Carlos García-Pagán
[J]. Annals of Hematology, 2020, 99 : 791 - 798
[9] Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis
Alvarez-Larran, Alberto
Pereira, Arturo
Magaz, Marta
Carlos Hernandez-Boluda, Juan
Garrote, Marta
Cuevas, Beatriz
Ferrer-Marin, Francisca
Teresa Gomez-Casares, M.
Garcia-Gutierrez, Valentin
Isabel Mata-Vazquez, M.
Turon, Fanny
Hernandez-Gea, Virginia
Arellano-Rodrigo, Eduardo
Cervantes, Francisco
Carlos Garcia-Pagan, Juan
[J]. ANNALS OF HEMATOLOGY, 2020, 99 (04) : 791 - 798
[10] Use of pegylated interferon in young patients with polycythemia vera and essential thrombocythemia
Kucine, Nicole
Bergmann, Shayla
Krichevsky, Spencer
Jones, Devin
Rytting, Michael
Jain, Juhi
Bennett, Carolyn M.
Resar, Linda M. S.
Mascarenhas, John
Verstovsek, Srdan
Hoffman, Ronald
[J]. PEDIATRIC BLOOD & CANCER, 2021, 68 (03)

← 1 2 3 4 5 →